Talis Biomedical Total Liabilities

Talis Biomedical (TLIS) currently reports a total liabilities of $24M as of June 2024. That compares with $27M in the prior-year period — down 10.5% year over year. Use the charts on this page to explore Talis Biomedical's total liabilities history and peer comparisons.

Talis Biomedical's total liabilities decreased from $27M to $24M — a 10.5% year-over-year decrease (period ending June 2024). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.

Talis Biomedical reported $24M in total liabilities as of June 2024. That compares with $27M in the prior-year period — down 10.5% year over year. Absolute dollar amounts are most useful when compared with prior periods, peers, and related line items such as revenue, assets, or liabilities on Stockcircle.

Start with the current total liabilities of $24M, then check the historical chart for trend and the peer comparison chart for relative positioning. From there, open related valuation or income-statement pages for Talis Biomedical, and consider following TLIS for alerts when major investors trade the stock.

Talis Biomedical is classified in the Healthcare sector. On total liabilities, it currently shows $24M. Sector peers often share similar capital intensity and growth regimes, so relative rankings inside Healthcare are usually more informative than comparing TLIS with unrelated industries.